Vir Biotechnology, Inc.: Form 8-K, filed Aug 1, 2024
Filed with the SEC on Aug 1, 2024 and accepted by EDGAR at Aug 1, 2024, 16:10 ET.
Items reported
- Item 2.02 Results of operations
- Item 2.05 Exit or disposal costs
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-24-034143. Last ingested by Listed: Oct 28, 2026, 08:38 ET. Listed shows no prices and gives no investment advice.